Showing results (2431-2440 of 4,091) with videos related to
Sort By:
Pageof 410
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1996
Fluticasone propionate compared with theophylline for mild-to-moderate asthmaS P Galant, M Lawrence, E O Meltzer, et al.Gynecologic Oncology|October 24, 1998
DNA content of ovarian immature teratomas and malignant germ cell tumorsB A Baker, L Frickey, I T Yu, et al.Psychopharmacology Bulletin|February 11, 2009
Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysisRoss A Baker, Andrei Pikalov, Quynh-Van Tran, et al.The American Journal of Psychiatry|January 17, 2009
Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agentsDan W Haupt, Lisa C Rosenblatt, Edward Kim, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|August 7, 2009
Detectable reporter gene expression following transduction of adenovirus and adeno-associated virus serotype 2 vectors within full-thickness osteoarthritic and unaffected canine cartilage in vitro and unaffected guinea pig cartilage in vivoKelly S Santangelo, Sarah A Baker, Gerard Nuovo, et al.Journal of Consulting and Clinical Psychology|January 27, 2010
Cognitive-behavioral therapy to promote smoking cessation among African American smokers: a randomized clinical trialMonica S Webb, Denise Rodríguez de Ybarra, Elizabeth A Baker, et al.The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Modulation of group II metabotropic glutamate receptor signaling by chronic cocaineZheng-Xiong Xi, Sammanda Ramamoorthy, David A Baker, et al.Seizure|May 25, 2002
The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological testsA P Aldenkamp, H F van Meel, G A Baker, et al.Journal of Public Health Management and Practice : JPHMP|March 21, 2000
Data uses, benefits, and barriers for the behavioral risk factor surveillance system: a qualitative study of usersY Bloom, L W Figgs, E A Baker, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|August 24, 2000
Vascular dementia and Alzheimer's disease: is there a difference? A comparison of symptoms by disease durationW C Groves, J Brandt, M Steinberg, et al.Pageof 410